Australian National Clinical Evidence Taskforce COVID-19 drug treatment guidelines: challenges of producing a living guideline.
Saved in:
| Title: | Australian National Clinical Evidence Taskforce COVID-19 drug treatment guidelines: challenges of producing a living guideline. |
|---|---|
| Authors: | Barber BE; QIMR Berghofer Medical Research Institute, Brisbane, QLD.; Royal Brisbane and Women's Hospital, Brisbane, QLD., White H; Monash University, Melbourne, VIC., Poole AP; Monash University, Melbourne, VIC.; Centre of Research Excellence in Translating Nutritional Science to Good Health, University of Adelaide, Adelaide, SA., Davis JS; John Hunter Hospital, Newcastle, NSW.; University of Newcastle, Newcastle, NSW., McGloughlin SA; Alfred Hospital, Melbourne, VIC., Turner T; Monash University, Melbourne, VIC. |
| Corporate Authors: | COVID-19 Drug Treatment Panel of the National Clinical Evidence Taskforce |
| Source: | The Medical journal of Australia [Med J Aust] 2023 Sep 04; Vol. 219 (5), pp. 197-199. Date of Electronic Publication: 2023 Jul 30. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Australasian Medical Publishing Co Country of Publication: Australia NLM ID: 0400714 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1326-5377 (Electronic) Linking ISSN: 0025729X NLM ISO Abbreviation: Med J Aust Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
